Product Information
FENOFIBRIC ACID DR 135 MG CAP is a generic product labeled by Micro Labs Limited, priced at $0.2863 per EA under NDC 42571034890. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Jun 16, 2020.
Strength
135 mg/1
Manufacturer
Micro Labs LimitedNDC
42571034890
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA213450FDA Approved
6/16/2020
On Market Since
9/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRIC ACID DR 135 MG CAP has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 58.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2863 per EA |
|---|---|
| All-time high | $0.6922 (Apr 13, 2022) |
| All-time low | $0.2366 (Mar 18, 2026) |
| 52-week high | $0.2947 |
| 52-week low | $0.2366 |
| Median price | $0.3613 |
| Average price | $0.3895 |
| Largest weekly change | +48.1% (Aug 21, 2024) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fenofibric acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fenofibric acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRIC ACID DR 135 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRIC ACID DR 135 MG CAP, manufactured by Micro Labs Limited, is $0.2863 per EA (NDC 42571034890), effective Sep 30, 2026.
How has the price of FENOFIBRIC ACID DR 135 MG CAP changed over time?
Over the history we have for it, the NADAC for FENOFIBRIC ACID DR 135 MG CAP has declined 58.6%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for FENOFIBRIC ACID DR 135 MG CAP?
Since Mar 23, 2022, the NADAC for FENOFIBRIC ACID DR 135 MG CAP has ranged from a low of $0.2366 (Mar 18, 2026) to a high of $0.6922 (Apr 13, 2022), with a median of $0.3613 per EA.
Are there cheaper alternatives to FENOFIBRIC ACID DR 135 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of FENOFIBRIC ACID DR 135 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENOFIBRIC ACID DR 135 MG CAP?
FENOFIBRIC ACID DR 135 MG CAP (NDC 42571034890) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.